News

NewsEpsilon09242022-05-11T21:40:55-07:00

Press Releases

Circle Pharma’s first-in-class orally bioavailable macrocyclic cyclin A/B inhibitors highlighted in poster presentations at American Association for Cancer Research Annual Meeting

19 April, 2023

Read More

Circle Pharma appoints Stephen Kelsey, MB ChB, MD, to its board of directors

15 December, 2022

Read More

Circle Pharma Appoints Paul Park, MBA, as its Chief Business Officer

26 July, 2022

Read More

Circle Pharma announces presentation at the American Association for Cancer Research 2022 Annual Meeting

11 April, 2022

Read More

Circle Pharma appoints Evelyn Wang, PhD as its Vice President, Translational Medicine

12 July, 2021

Read More

Circle Pharma raises $66 Million in Series C Financing

16 June, 2021

Read More

Circle Pharma appoints Constantine Kreatsoulas, PhD as its Vice President, Research Informatics and Computational Chemistry

1 February, 2021

Read More

Circle Pharma Appoints James Aggen, PhD as Its Vice President, Medicinal Chemistry

26 October, 2020

Read More

Circle Pharma Appoints Alan Ashworth, PhD, FRS and Bruce Stillman, PhD, FRS to Its SAB

21 October, 2020

Read More

Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer

20 July, 2020

Read More

Circle Pharma Appoints William G. Kaelin Jr. MD as Chair of Its Scientific Advisory Board

27 May, 2020

Read More

Circle Pharma raises $45 Million in Series B Financing

17 March, 2020

Read More

Circle Pharma Congratulates Dr. William G. Kaelin, Jr., MD on Award of Nobel Prize

9 October, 2019

Read More

Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc.

17 January, 2018

Read More

Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer

20 November, 2017

Read More

Circle Pharma announces expansion of Series A financing and appointment of James C. Lu to its board

25 April, 2017

Read More

Circle Pharma announces Series A financing and appoints Walter H. Moos, Ph.D., to its board

21 December, 2016

Read More

Circle Pharma enters into an agreement with Pfizer to build screening library of macrocyclic peptides

12 September, 2016

Read More

Circle Pharma Announces Appointment of Co-Founder Prof. Matthew Jacobson to Department Chair

19 January, 2016

Read More

Circle Pharma Announces Receipt of Additional Seed Investment, and Relocation to New Laboratory Facility

7 January, 2016

Read More

Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations

22 September, 2014

Read More